VRNA logo

Verona Pharma plc (VRNA) Cash From Operations

Annual CFO:

-$122.20M-$71.98M(-143.33%)
December 31, 2024

Summary

  • As of today, VRNA annual cash from operations is -$122.20 million, with the most recent change of -$71.98 million (-143.33%) on December 31, 2024.
  • During the last 3 years, VRNA annual cash from operations has fallen by -$88.95 million (-267.48%).
  • VRNA annual cash from operations is now -3594305.88% below its all-time high of $3400.00, reached on December 31, 2005.

Performance

1-Year Change

-143.33%

3-Year Change

-267.48%

5-Year Change

-185.07%

15-Year Change

-336.93%

VRNA Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

10.68%
VRNA annual cash from operations is higher than 10.68% of companies in Healthcare sector

Range

All-Time High

$3400.00
VRNA annual cash from operations is currently >-9900.00% below its historical high of $3400.00

3-Year Low

-$122.20M
VRNA annual cash from operations is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
VRNA previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
VRNA next annual earnings announcement has not yet been scheduled

OtherVRNAcash flow metrics

Annual CFI

-$580.00K
VRNA annual cash from investing is -$580.00 thousand

Annual CFF

$250.88M
VRNA annual cash from financing is $250.88 million

Annual FCF

-$122.78M
VRNA annual free cash flow is -$122.78 million

Annual CAPEX

$580.20K
VRNA annual capital expenditures is $580.20 thousand

Quarterly CFO:

$30.77M+$42.37M(+365.12%)
June 1, 2025

Summary

  • As of today, VRNA quarterly cash from operations is $30.77 million, with the most recent change of +$42.37 million (+365.12%) on June 1, 2025.
  • Over the past year, VRNA quarterly cash from operations has increased by +$47.52 million (+283.63%).
  • VRNA quarterly cash from operations is now at all-time high.

Performance

3-Month Change

+365.12%

1-Year Change

+283.63%

3-Year Change

+258.65%

5-Year Change

+1098.69%

VRNA Quarterly Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

84.97%
VRNA quarterly cash from operations is higher than 84.97% of companies in Healthcare sector

Range

All-Time High

$30.77M
VRNA quarterly cash from operations is currently at an all-time high

3-Year Low

-$63.07M
VRNA quarterly cash from operations is currently +148.79% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 1, 2025
VRNA previous earnings announcement was published on Jun 1, 2025

Next Quarterly Earnings Report Date

Nov 3, 2025
VRNA next earnings announcement is scheduled for Nov 3, 2025

OtherVRNAcash flow metrics

Quarterly CFI

-$2500.00
VRNA quarterly cash from investing is -$2500.00

Quarterly CFF

$5.05M
VRNA quarterly cash from financing is $5.05 million

Quarterly FCF

$30.77M
VRNA quarterly free cash flow is $30.77 million

Quarterly CAPEX

$2500.00
VRNA quarterly capital expenditures is $2500.00

TTM CFO:

-$72.37M+$47.52M(+39.64%)
June 1, 2025

Summary

  • As of today, VRNA TTM cash from operations is -$72.37 million, with the most recent change of +$47.52 million (+39.64%) on June 1, 2025.
  • Over the past year, VRNA TTM cash from operations has dropped by -$18.50 million (-34.33%).
  • VRNA TTM cash from operations is now -1541.74% below its all-time high of -$4.41 million, reached on March 31, 2017.

Performance

3-Month Change

+39.64%

1-Year Change

-34.33%

3-Year Change

-155.83%

5-Year Change

-92.32%

VRNA TTM Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

19.68%
VRNA TTM cash from operations is higher than 19.68% of companies in Healthcare sector

Range

All-Time High

-$4.41M
VRNA TTM cash from operations is currently -1541.74% below its historical high of -$4.41 million

3-Year Low

-$122.25M
VRNA TTM cash from operations is currently +40.80% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 1, 2025
VRNA previous earnings announcement was published on Jun 1, 2025

Next Quarterly Earnings Report Date

Nov 3, 2025
VRNA next earnings announcement is scheduled for Nov 3, 2025

OtherVRNAcash flow metrics

TTM CFI

-$1.07M
VRNA TTM cash from investing is -$1.07 million

TTM CFF

$105.68M
VRNA TTM cash from financing is $105.68 million

TTM FCF

-$73.44M
VRNA TTM free cash flow is -$73.44 million

TTM CAPEX

$1.07M
VRNA TTM capital expenditures is $1.07 million

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

VRNA Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-143.3%+283.6%-34.3%
3Y3 Years-267.5%+258.6%-155.8%
5Y5 Years-185.1%+1098.7%-92.3%

VRNA Cash From Operations Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-267.5%at lowat high+148.8%-50.0%+40.8%
5Y5-Year-267.5%at lowat high+148.8%-353.2%+40.8%
All-TimeAll-Time>-9999.0%at lowat high+148.8%-1541.7%+40.8%

VRNA Cash From Operations History

DateAnnualQuarterlyTTM
Jun 2025
-
$30.77M(+365.1%)
-$72.37M(+39.6%)
Mar 2025
-
-$11.61M(+59.2%)
-$119.89M(+1.9%)
Dec 2024
-$122.20M(-143.3%)
-$28.47M(+54.9%)
-$122.25M(-17.3%)
Sep 2024
-
-$63.07M(-276.4%)
-$104.21M(-93.4%)
Jun 2024
-
-$16.76M(-20.0%)
-$53.87M(+8.0%)
Mar 2024
-
-$13.97M(-34.0%)
-$58.55M(-16.1%)
Dec 2023
-$50.22M(+16.1%)
-$10.42M(+18.1%)
-$50.42M(-4.5%)
Sep 2023
-
-$12.73M(+40.6%)
-$48.23M(+9.4%)
Jun 2023
-
-$21.43M(-267.3%)
-$53.27M(-4.0%)
Mar 2023
-
-$5.83M(+29.2%)
-$51.23M(+14.4%)
Dec 2022
-$59.86M(-80.0%)
-$8.24M(+53.6%)
-$59.83M(+13.1%)
Sep 2022
-
-$17.76M(+8.4%)
-$68.87M(-143.5%)
Jun 2022
-
-$19.39M(-34.4%)
-$28.29M(+2.7%)
Mar 2022
-
-$14.43M(+16.5%)
-$29.06M(+12.6%)
Dec 2021
-$33.25M(+26.2%)
-$17.28M(-175.7%)
-$33.25M(-108.2%)
Sep 2021
-
$22.82M(+213.1%)
-$15.97M(+67.3%)
Jun 2021
-
-$20.17M(-8.3%)
-$48.86M(-53.8%)
Mar 2021
-
-$18.62M(-84.7%)
-$31.77M(+15.6%)
Dec 2020
-$45.08M(-5.2%)
-
-
Sep 2020
-
-$10.08M(-227.1%)
-$37.63M(-8.3%)
Jun 2020
-
-$3.08M(+76.7%)
-$34.74M(+17.6%)
Mar 2020
-
-$13.23M(-17.7%)
-$42.17M(-1.3%)
Dec 2019
-$42.87M
-$11.24M(-56.3%)
-$41.62M(-13.0%)
DateAnnualQuarterlyTTM
Sep 2019
-
-$7.19M(+31.6%)
-$36.83M(-24.0%)
Jun 2019
-
-$10.51M(+17.1%)
-$29.70M(-9.1%)
Mar 2019
-
-$12.68M(-96.6%)
-$27.22M(-17.7%)
Dec 2018
-$22.98M(+17.8%)
-$6.45M(>-9900.0%)
-$23.13M(-0.5%)
Sep 2018
-
-$57.50K(+99.3%)
-$23.00M(+30.0%)
Jun 2018
-
-$8.03M(+6.5%)
-$32.85M(-5.9%)
Mar 2018
-
-$8.59M(-35.8%)
-$31.02M(-15.6%)
Dec 2017
-$27.97M(-305.8%)
-$6.33M(+36.1%)
-$26.84M(-30.8%)
Sep 2017
-
-$9.91M(-59.7%)
-$20.52M(-93.3%)
Jun 2017
-
-$6.20M(-40.7%)
-$10.61M(-140.7%)
Mar 2017
-
-$4.41M
-$4.41M
Dec 2016
-$6.89M(+26.8%)
-
-
Dec 2015
-$9.42M(-70.9%)
-
-
Dec 2014
-$5.51M(-62.7%)
-
-
Dec 2013
-$3.39M(+17.0%)
-
-
Dec 2012
-$4.08M(-67.0%)
-
-
Dec 2011
-$2.44M(+4.6%)
-
-
Dec 2010
-$2.56M(+2.3%)
-
-
Dec 2009
-$2.62M(-32.6%)
-
-
Dec 2008
-$1.98M(+17.3%)
-
-
Dec 2007
-$2.39M(-247.5%)
-
-
Dec 2006
-$687.70K(>-9900.0%)
-
-
Dec 2005
$3400.00
-
-

FAQ

  • What is Verona Pharma plc annual cash from operations?
  • What is the all-time high annual cash from operations for Verona Pharma plc?
  • What is Verona Pharma plc annual cash from operations year-on-year change?
  • What is Verona Pharma plc quarterly cash from operations?
  • What is the all-time high quarterly cash from operations for Verona Pharma plc?
  • What is Verona Pharma plc quarterly cash from operations year-on-year change?
  • What is Verona Pharma plc TTM cash from operations?
  • What is the all-time high TTM cash from operations for Verona Pharma plc?
  • What is Verona Pharma plc TTM cash from operations year-on-year change?

What is Verona Pharma plc annual cash from operations?

The current annual cash from operations of VRNA is -$122.20M

What is the all-time high annual cash from operations for Verona Pharma plc?

Verona Pharma plc all-time high annual cash from operations is $3400.00

What is Verona Pharma plc annual cash from operations year-on-year change?

Over the past year, VRNA annual cash from operations has changed by -$71.98M (-143.33%)

What is Verona Pharma plc quarterly cash from operations?

The current quarterly cash from operations of VRNA is $30.77M

What is the all-time high quarterly cash from operations for Verona Pharma plc?

Verona Pharma plc all-time high quarterly cash from operations is $30.77M

What is Verona Pharma plc quarterly cash from operations year-on-year change?

Over the past year, VRNA quarterly cash from operations has changed by +$47.52M (+283.63%)

What is Verona Pharma plc TTM cash from operations?

The current TTM cash from operations of VRNA is -$72.37M

What is the all-time high TTM cash from operations for Verona Pharma plc?

Verona Pharma plc all-time high TTM cash from operations is -$4.41M

What is Verona Pharma plc TTM cash from operations year-on-year change?

Over the past year, VRNA TTM cash from operations has changed by -$18.50M (-34.33%)
On this page